CBS 2019
CBSMD教育中心
English

左主干支架

科研文章

荐读文献

Revascularization of left main coronary artery Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study) Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention: An Analysis of the British Cardiovascular Intervention Society Database Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries

Expert Opinion2017 Feb 28;135(9):822-824.

JOURNAL:Circulation. Article Link

Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials

Ruel M, Farkouh ME. Keywords: clinical trials as topics; coronary artery disease; patient outcome assessment; percutaneous coronary intervention; surge

ABSTRACT